首页> 外文期刊>RSC Advances >A review on the medicinal potential of Panax ginseng saponins in diabetes mellitus
【24h】

A review on the medicinal potential of Panax ginseng saponins in diabetes mellitus

机译:人参皂苷在糖尿病中的药用研究进展。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Herbal medicines have traditionally played a major role in the management of diabetes mellitus (DM) in Asian countries for centuries. In the last decade, numerous preclinical findings suggested that Panax ginseng C. A. Meyer was a promising therapeutic agent for the prevention and treatment of DM, and Panax ginseng saponins were the key active components. The present review highlights the effects of ginseng and its active specific ginsenosides on glucose production and absorption, insulin production/secretion, and on inflammatory processes that seem to play an important role in the development of DM. However, the studies are remained inconclusive because of contradictory results. Thus more studies are needed to further prove the efficacy in DM. This review summarizes the evidences for the therapeutic potential of ginseng and ginsenosides from in vitro studies, animal studies and human clinical trials with a focus on diverse molecular targets.
机译:传统上,数百年来,草药一直在亚洲国家的糖尿病(DM)管理中发挥重要作用。在过去的十年中,大量的临床前发现表明人参C. A. Meyer是预防和治疗DM的有前途的治疗剂,而人参皂苷是关键的活性成分。本文概述了人参及其活性特定人参皂苷对葡萄糖生成和吸收,胰岛素生成/分泌以及炎症过程的影响,这些作用似乎在DM的发展中起重要作用。但是,由于结果矛盾,研究仍未定论。因此,需要更多的研究来进一步证明DM的功效。这篇综述总结了体外研究,动物研究和人类临床试验对人参和人参皂甙具有治疗潜力的证据,重点是各种分子靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号